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Abstract 
Background: Rotational beam delivery enables concurrent acquisition of cone‑beam CT (CBCT), thereby facilitating 
further geometric verification of patient setup during radiation treatment. However, it is challenging to acquire CBCT 
during stereotactic body radiation therapy (SBRT) using flattening‑filter free X‑ray beams, in which a high radiation 
dose is delivered. This study presents quantitative evaluation results of the image quality in four‑dimensional (4D) in‑
treatment CBCT acquired during SBRT delivery.
Methods: The impact of megavoltage (MV) scatter and acquisition parameters on the image quality was evalu‑
ated using Catphan 503 and XSight lung tracking phantoms. The in‑treatment CBCT images of the phantoms were 
acquired while delivering 16 SBRT plans. The uniformity, contrast, and contrast‑to‑noise ratio (CNR) of the in‑treatment 
CBCT images were calculated and compared to those of CBCT images acquired without SBRT delivery. Furthermore, 
the localizing accuracy of the moving target in the XSight lung phantom was evaluated for 10 respiratory phases.
Results: The CNR of the 3D‑reconstucted Catphan CBCT images was reduced from 6.3 to 2.6 due to the effect of MV 
treatment scatter. Both for the Catphan and XSight phantoms, the CBCT image quality was affected by the tube cur‑
rent and monitor units (MUs) of the treatment plan. The lung target in the XSight tracking phantom was most visible 
for extreme phases; the mean CNRs of the lung target in the in‑treatment CBCT images (with 40 mA tube current) 
across the SBRT plans were 3.2 for the end‑of‑exhalation phase and 3.0 for the end‑of‑inhalation phase. The lung 
target was localized with sub‑millimeter accuracy for the extreme respiratory phases.
Conclusions: Full‑arc acquisition with an increased tube current (e.g. 40 mA) is recommended to compensate for 
degradation in the CBCT image quality due to unflattened MV beam scatter. Acquiring in‑treatment CBCT with a 
high‑MU treatment beam is also suggested to improve the resulting CBCT image quality.
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Background
For lung stereotactic body radiation therapy (SBRT), 
appropriate management of respiratory motion is criti-
cal for accurate delivery of radiation beams to the target. 
Respiratory motion of lung target has been managed by 
various techniques, such as motion encompassing, res-
piratory gating, breath-hold, and forced shallow breath-
ing with abdominal compression as described in the 
report of the American Association of Physicists in Med-
icine Task Group 76 [1].
Monitoring during-treatment position of the lung 
target is essential for all motion management tech-
niques. For instance, for respiratory gating techniques, 
beam delivery is triggered by gating signals, either 
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amplitude-based or phase-based, obtained using exter-
nal surrogate markers [2–4] or implanted fiducial mark-
ers [5–7]. Furthermore, for motion-encompassing 
techniques, although the internal target volume is defined 
to cover the entire range of the lung target motion due 
to the patient’s respiration, it is still necessary to verify 
that the lung target moves within the pre-defined range 
estimated using four-dimensional (4D) respiratory-
correlated CT. While fluoroscopic image-based target 
monitoring is a well-established method for CyberKnife, 
which is a robotic radiosurgery system equipped with 
an orthogonal pair of x-ray imaging devices, it has been 
recently investigated for C-arm linac machines [8–10].
To monitor intrafraction position of the radiation tar-
get during volumetric-modulated arc therapy (VMAT)-
based lung SBRT, kV projections have been obtained 
during VMAT delivery and reconstructed to 3D or 4D 
cone-beam CT (hereinafter, referred to as in-treatment 
CBCT). The clinical feasibility of acquiring CBCT dur-
ing VMAT delivery was evaluated by initial studies [11–
14]. Furthermore, 4D in-treatment CBCT was clinically 
implemented to evaluate lung target coverage across all 
respiratory phases during VMAT-based SBRT [15, 16].
The image quality of in-treatment CBCT has been 
evaluated in recent studies [17, 18]. Shimohigashi et  al. 
investigated the impact of prescription dose (dose rate 
or gantry speed) on the image quality of 4D in-treatment 
CBCT images [18]. However, in the previous studies, in-
treatment CBCT images were acquired only under rela-
tively moderate dose rates without considering flattening 
filter-free (FFF) X-ray beams; FFF X-ray beams have been 
frequently used for lung SBRT due to their high dose rate, 
thereby reducing the total beam-on time. It is an interest-
ing research question how visible the lung target is on 4D 
in-treatment CBCT acquired with concurrent delivery of 
such highly intensive radiation beams.
To the best of the author’s knowledge, this study is the 
first to evaluate the image quality of 4D in-treatment 
CBCT acquired during lung SBRT using FFF x-ray 
beams. Phantom studies were performed (1) to quanti-
tatively evaluate the megavoltage (MV) treatment beam 
scatter, (2) to investigate the impact of the acquisition 
parameters (tube current, acquisition angle, MV treat-
ment beam energy, and plan-specific parameter (e.g. 
monitor unit (MU)) on the image quality, and (3) to eval-
uate the visibility and localization of the lung target for 
each respiratory phase using 4D in-treatment CBCT.
Methods
Overview
Phantom studies were performed to evaluate the image 
quality of 4D in-treatment CBCT. The following aspects 
were mainly investigated in this study: (1) the impact of 
the MV beam scatter on the CBCT image quality, (2) 
the impact of the acquisition parameters on the CBCT 
image quality, (3) the accuracy of localizing the lung 
target on the respiratory phases. Two phantoms were 
used for these investigations (see Fig. 1): a Catphan 503 
phantom (The Phantom Laboratory, Salem, NY, USA) 
and an XSight lung tracking phantom (CIRS Inc., Nor-
folk, VA, USA). It is noted that the study of using the 
Catphan phantom was performed without a motion 
platform and the CBCT image quality was evaluated on 
3D-reconstructed images. As preliminary steps towards 
the evaluation of 4D in-treatment CBCT images of the 
XSight lung tracking phantom, the impact the acquisi-
tion parameters as well as the impact of the MV scatter 
was evaluated using the 3D Catphan CBCT images. The 
impact of the acquisition parameters and localization 
accuracy/visibility of the lung target were investigated on 
the 4D XSight tracking phantom.
Impact of MV treatment beam scatter
In order to quantitatively evaluate the impact of the MV 
treatment beam scatter on the CBCT image quality, 
CBCT scans of the Catphan 503 phantom were acquired 
Fig. 1 Phantoms used to evaluate cone‑beam CT image quality: a Catphan 503 phantom and b XSight lung tracking phantom
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with four different imaging protocols as summarized in 
Table 1 using a gantry-mounted kV imager (XVI, Elekta 
Oncology Systems). The pretreatment CBCT imaging 
protocols used in this investigation are currently clinically 
used to examine patients with a lung target. It should be 
noted that, for the sake of simplicity, CBCT acquired 
without MV treatment beam delivery is denoted by pre-
treatment CBCT since, in general, it is acquired prior to 
treatment for patient setup. As an initial test, the in-treat-
ment CBCT imaging protocols in Table 1 were created by 
simply adding the parameters specifically required for in-
treatment CBCT acquisition without adjusting the other 
acquisition parameters, such as the tube voltage, tube 
current, exposure time, and rotation angle.
For the intrafraction CBCT acquisition, a VMAT plan 
for a lung cancer patient (patient 1) was delivered to the 
Catphan phantom. A two-arc VMAT plan was created 
for the lung SBRT using FFF 10 MV X-ray beams. Among 
the two arcs, the first arc plan, which was delivered dur-
ing the CBCT acquisition, was created to deliver 2585.3 
MU in 77 s along a full-arc gantry rotation (from − 179° 
to 179°). The corresponding gantry speed to deliver the 
first arc of the VMAT plan was estimated to be approxi-
mately 279°/min on average. The average planned dose 
rate was estimated to be 2014.5 MU/min.
For the CBCT acquisitions, two-dimensional pro-
jections were acquired and then reconstructed to 
multiple-phase three-dimensional image volumes. Prior 
to the CBCT reconstruction, the acquired projections 
were sorted into ten respiratory phases (0, 10, 20, …, 90) 
by an automatic phase-sorting algorithm [19] in XVI. 
Among the ten respiratory phases, 0-phase and 50-phase 
represent end-of-exhalation and end-of-inhalation 
phases, respectively, and the other eight phases represent 
intermediate phases between the end respiratory phases.
It is noteworthy to mention that different numbers of 
projections were acquired for the pretreatment and in-
treatment CBCT protocols due to the concurrent deliv-
ery of MV treatment beams for the in-treatment CBCT 
as summarized in Table  1. For the in-treatment CBCT 
acquisition, it is not necessary to define the gantry speed 
since the linac gantry rotates with time-varying angular 
speeds, which are optimized for radiotherapy treatment 
plan. Consequently, the number of projections acquired 
for the in-treatment CBCT could vary depending on 
the VMAT plans delivered with the CBCT acquisition. 
Instead of defining the gantry speed, an angular interval, 
so called the acquisition interval in XVI, was defined for 
acquiring the in-treatment CBCT; the acquisition inter-
val is an acquisition parameter that defines the minimum 
gantry rotation, upon which kV projection acquisition 
is triggered (0.1° for this study as suggested in a previ-
ous study [20]). As summarized in Table  1, more pro-
jections were acquired for the three-dimensional (3D) 
Table 1 Summary of four cone-beam CT imaging protocols used in this study
The CBCT acquired without MV treatment beam delivery is denoted by pretreatment CBCT as it is acquired prior to treatment. The results of an initial image quality 
test for the listed protocols are summarized
a The time for the in-treatment CBCT images was estimated as the beam-on time expected to deliver the VMAT plan for patient 1. In general, the time to acquire an 
in-treatment CBCT image varies depending on the VMAT plan, which is concurrently delivered
3D 4D
Pretreatment In-treatment Pretreatment In-treatment
Image acquisition parameters
 MV treatment beam No Yes No Yes
 Tube voltage (kV) 120 120 120 120
 Tube current (mA) 40 40 20 20
 Exposure time (ms) 40 40 16 16
 Collimator M20 M20 S20 S20
 Rotation angle (°) 360 360 200 200
 Gantry speed (°/min) 360 – 67 –
 Acquisition interval (°) – 0.1 – 0.1
 Estimated time (s)a 60 99 180 55
Analysis results
 #projections acquired 333 512 1010 266
 Contrast (%) 9.6 10.1 8.0 5.5
 Contrast‑to‑noise ratio 10.0 9.5 10.7 2.6
 Overall uniformity (%) 98.5 98.0 97.1 89.1
 Minimum uniformity (%) 98.8 98.4 98.4 95.7
Page 4 of 13Kim et al. Radiat Oncol          (2020) 15:224 
in-treatment CBCT than the 3D pretreatment CBCT: 
495 vs. 333 projections. On the other hand, a larger 
number of projections was acquired for the 4D pretreat-
ment CBCT (1010) than for the 4D in-treatment CBCT 
(266) as gantry rotated more slowly for 4D pretreatment 
CBCT. Since the CBCT image quality is largely affected 
by the number of projections acquired [21–23], it was not 
feasible to evaluate the effect of the MV scatter from the 
results in Table 1.
In order to more appropriately evaluate the impact of 
the MV scatter on the CBCT image quality, the gantry 
speed of the 3D and 4D pretreatment CBCT imaging 
protocols was adjusted. For the 3D pretreatment CBCT 
acquisition, the gantry speed was reduced from 360 to 
240°/min. For the 4D pretreatment CBCT acquisition, 
the gantry speed was adjusted from 67 to 254°/min. By 
adjusting the gantry speed, similar numbers of projec-
tions were acquired for the pretreatment and in-treat-
ment CBCT protocols, leading to a fair comparison of 
the image quality between the pretreatment and in-treat-
ment CBCTs. It should be noted that the aforementioned 
adjustments of the gantry speed, which largely affected 
the resulting CBCT image quality, were performed only 
for evaluating the MV scatter effect. For the other experi-
ments, pretreatment CBCT images were acquired with 
the standard imaging protocols summarized in Table  1. 
The kV projections acquired with the 3D and 4D imaging 
protocols were reconstructed into 3D CBCT images.
To quantitatively evaluate the image quality of the 
3D-reconstructed CBCT images, several image qual-
ity metrics were calculated using DoseLab Pro 7.0 (Var-
ian Medical Systems, Palo Alto, CA, USA), an image 
analysis software package. As illustrated in Fig.  2, the 
Catphan 503 phantom consisted of three modules, each 
of which was used to analyze different image quality 
metrics: the contrast and contrast-to-noise ratio (CNR) 
(CTP404 in Fig. 2a), and the overall and minimum uni-
formity (CTP486 in Fig.  2b). First, the CTP404 module 
has multiple inserts with various electron density values; 
10 regions of interest (ROIs) detected by DoseLab are 
displayed in Fig. 2a. For this investigation, ROIs 1 (water-
equivalent) and 2 (Delrin) were used to calculate contrast 
and CNR as follows:
where S1 and S2 represents the mean pixel values of ROIs 
1 and 2, respectively, whereas σ1 and σ2 represents the 
standard deviations of the pixel values in ROIs 1 and 2, 
respectively. Second, overall and minimum uniformities 
were calculated for ROIs 19–23 using an equation that 
calculates the uniformity metric for a region:
where S90 and S10 represent the 90th and 10th percentile 
of the pixel values in an ROI, respectively. The overall 



























Fig. 2 Axial cuts of two modules in the Catphan 503 phantom visualized with regions of interest used for quantitative evaluations of CBCT image 
quality. The two modules, a CTP404 and b CTP486, were used to calculate the contrast‑ and uniformity‑related metrics, respectively
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for all of the ROIs. The minimum uniformity was calcu-
lated as the lowest value among the uniformity values 
calculated for each of ROIs 19–23.
Impact of tube current, acquisition angle, and treatment 
beam energy
The impact of several important image acquisition 
parameters, such as the kV tube current, acquisition 
angle, and treatment beam energy, on the CBCT image 
quality was evaluated. Since image quality degradation 
was expected due to the MV scatter, the tube current was 
increased from 20  mA (vendor-recommended value for 
4D pretreatment CBCT) to 25, 32, 40, and 50  mA. The 
4D pretreatment protocol was the vendor-recommended 
CBCT imaging protocol for the patient thorax, known 
as the Symmetry protocol, as described in Table  1. In 
the Symmetry protocol, the gantry rotation is limited to 
200°. In this investigation, for the 4D in-treatment CBCT 
acquisition, the Symmetry protocol was modified so that 
the CBCT projections were acquired during a full-arc 
rotation. The rationales behind acquiring 4D in-treat-
ment CBCT with a full-arc rotation can be explained as 
follows: (1) full-arc acquisition can maximally cover the 
angular range of VMAT treatment beams, and (2) a larger 
number of projections can be acquired with a full-arc 
acquisition, leading to improved image quality. In order 
to investigate the impact of the treatment beam energy, 
for patient 1, another VMAT plan using 6 MV FFF was 
created so that the resulting dose distribution was similar 
to that with 10 MV FFF. The 6 MV FFF VMAT plan deliv-
ered 2805.2 MU in 99 s (estimated) for the first arc deliv-
ery; this case was referred to as patient 2 for simplicity 
of explanation. The CBCT image quality metrics defined 
above were calculated for all 3D-reconstructed CBCT 
images.
CBCT acquisitions with various VMAT plans
It was investigated how the in-treatment CBCT image 
quality varies depending on the VMAT plan concurrently 
delivered with the CBCT acquisition. While each of the 
first-arc beams of 16 patient VMAT plans, which were 
created to treat lung cancer patients, was delivered to the 
Catphan phantom, kV projections were acquired with 
tube currents of 20 and 40 mA. The acquired projections 
were reconstructed into 3D CBCT images for the image 
quality evaluation. The MUs delivered during the arc 
delivery differed depending on the VMAT plan (prescrip-
tion dose per fraction, number of arcs): 2062.6 ± 1221.2 
MU (153.8 to 4524.9 MU); the fractional dose ranged 
from 8 to 12  Gy. Among the 16 VMAT plans, 11 plans 
were created using 6 MV FFF X-ray beams and 5 plans 
were created using 10 MV FFF x-ray beams. The quan-
titative image quality metrics explained above were 
calculated using DoseLab. The relationships between 
the CBCT image quality metrics and MUs (or number of 
projections acquired) were examined by calculating the 
Pearson correlation coefficient using MATLAB (Math-
Works, Natick, MA, USA).
Visibility and localization accuracy of lung target
An XSight lung tracking phantom was used to evaluate 
the visibility and localization accuracy of the lung target 
using 4D in-treatment CBCT. The lung tracking phan-
tom consists of several anatomic regions with different 
physical densities, such as bony elements, soft tissue, and 
lungs, mimicking the patient thorax. A soft tissue target, 
which is a sphere with a diameter of 2.5 cm, was designed 
to move in the superior-inferior direction with a breath-
ing cycle of 5 s and an excursion of 29.5 mm. The accu-
racy of localizing this moving target was evaluated for 
each of 10 respiratory phases by comparing the superior-
inferior coordinates of the target center obtained using 
the 4D in-treatment CBCT images to those obtained 
using a 4D pretreatment CBCT image. The 16 VMAT 
plans were delivered during the in-treatment kV projec-
tion acquisition with tube currents of 20 and 40 mA. The 
kV projections were reconstructed into ten-phase 4D in-
treatment CBCT images by an automatic phase-sorting 
algorithm [19], which is designed to detect dominant 
positional changes across projections.
Furthermore, the CNR for the in-treatment 4D CBCT 
data sets of the XSight lung tracking phantom was cal-
culated by locating a spherical volume with a diam-
eter of 2.5  cm at the center of the lung target, which 
was obtained for the 4D pretreatment CBCT image as 
described in Fig. 3. The background HU value was calcu-
lated by defining a spherical shell with 1.0 cm thickness 
surrounding the spherical target structure. The CNR for 
the lung target in the XSight lung tracking phantom was 
calculated as follows:
where ST and SB represent the mean HU values for the 
target and background, respectively, whereas the stand-
ard deviations of the HU values for the target and back-
ground are denoted by σT and σB, respectively. The CNR 
calculated for the XSight lung tracking phantom esti-
mates the differentiability of the solid lung target from 
the surrounding materials (lung) compared to their noise 
level. An example of the CNR calculation was presented 
in Fig. 3: the resulting CNR was for the 0-phase pretreat-
ment CBCT image was 5.6, indicating that the mean 
signal difference between the target and background 
was 5.6 times greater than the mean noise level of the 
two regions. A correlation analysis was performed to 
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calculate the Pearson correlation coefficient between the 
CNR and MUs. A paired two-tailed t-test was conducted 
to evaluate a hypothesis that the CNRs between the 20 
and 40 mA tube currents were statistically different. The 
statistical significance in the CNR differences was evalu-
ated with a 95% confidence using MATLAB. The CNR 
data were approximately normally distributed, not violat-
ing the assumption for the t-test.
Results
Impact of MV treatment beam scatter
Table  2 compares the image quality of the 3D-recon-
structed Catphan  CBCT images acquired with the four 
different protocols. The uniformity measures slightly 
decreased due to the MV treatment beam scatter both 
for the 3D and 4D CBCT imaging protocols, indicating 
an increase in noise. Furthermore, the CNR decreased 
from 14.9 to 9.5 for the 3D CBCT protocol and from 
6.3 to 2.6 for the 4D CBCT protocol due to a decrease 
in contrast and an increase in noise level resulting from 
the MV scatter. The impact of the number of projections 
on the CBCT image quality was successfully suppressed 
as can be observed from the fact that similar numbers of 
projections were obtained for the pretreatment and in-
treatment CBCT images.
Impact of tube current, acquisition angle, and treatment 
beam energy
The quality of the 3D-reconstructed  Catphan CBCT 
images acquired with various tube currents (20, 25, 32, 
40, and 50  mA), acquisition angles (200° and 360°), and 
treatment beam energies (6 and 10 MV FFF) was quanti-
tatively analyzed and the results are summarized in Fig. 4. 
First, in general, as the tube current increased, the CBCT 
image quality was improved. Specifically, the CNR, over-
all uniformity, and minimum uniformity were improved 
as the tube current increased from 20 to 50 mA.
Second, a larger number of projections was acquired 
for the full-arc acquisition compared to the standard 
200° acquisition. For the CBCT scans acquired with the 
10 MV FFF VMAT plan delivery, the number of kV pro-
jections acquired was 270 ± 4 for the partial-arc (200°) 
acquisition compared to 541 ± 10 for the full-arc acqui-
sition. All quantitative measures were improved by the 
full-arc acquisition. The mean CNRs for the partial-arc 
and full-arc acquisitions were 4.1 and 5.8, respectively 
(Fig.  4). The overall uniformity increased, on average, 
from 90.5 to 96.7 by increasing the acquisition angular 
range from 200° to 360°.
Third, when comparing the CBCT image quality 
between the in-treatment CBCT images acquired with 
the delivery of the 6 and 10 MV FFF VMAT plans, two 
major factors need to be considered: (1) the MV treat-
ment beam scatter and (2) the total number of kV pro-
jections. A larger number of projections (619 ± 1) was 
acquired for the CBCT images acquired with the 6 MV 
FFF VMAT plan compared to those with the 10 MV FFF 
VMAT plan due to the lower dose (MU) rate (therefore, 
longer treatment time). The effect of the MV treatment 
beam scatter on the CBCT image quality is expected to 
be large for low treatment beam energy as reported in 
Fig. 3 Illustration of the contrast‑to‑noise ratio (CNR) calculation for 
the spherical moving target in the XSight lung tracking phantom. On 
the a axial and b sagittal cuts that intersect with the target center, 
two circles are displayed, which represent the boundaries of the 
target (sphere) and background (spherical shell). The resulting CNR 
was 5.6 for the 0‑phase (end of exhalation) pretreatment CBCT image
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previous work [17]. As a result, the impact of the MV 
treatment beam energy differed for the contrast and 
CNR. The contrast was higher for the CBCT images 
acquired with the 10 MV FFF VMAT plan while the CNR 
was higher for those acquired with the 6 MV FFF VMAT 
plan, indicating a low level of noise, which was possibly 
due to the large number of projections. The MV treat-
ment beam energy was found to have a negligible influ-
ence on the overall and minimum uniformities. Overall, 
the CBCT image quality was more affected by the acqui-
sition angle than the MV treatment beam energy as illus-
trated in Fig. 4.
CBCT acquisitions with various VMAT plans
Figure 5 presents the quantitative analysis results of the 
image quality for the 3D-reconstructed CBCT images of 
the Catphan phantom, obtained concurrently with the 16 
VMAT plans. In Fig. 5, each of the image quality metrics 
is plotted against the MUs with the Pearson correlation 
coefficient r and corresponding p-value p (calculated for 
95% statistical significance) presented.
The image quality metrics at a high tube current 
(40  mA) were more significantly affected by the VMAT 
plans (or MUs) than those at low tube current (20 mA) 
as can be observed from the Pearson correlation coeffi-
cients and p-values. The Pearson correlation coefficients 
were higher with smaller p-values for the CBCT images 
acquired with 40  mA than those acquired with 20  mA. 
For instance, the Pearson correlation coefficients for the 
CNR were − 0.10 (p = 0.70) for 20 mA vs. 0.40 (p = 0.13) 
for 40 mA. For the 40 mA tube current, when more MUs 
were delivered, a higher CNR resulted from the in-treat-
ment CBCT. Similar (positive) correlations with the MUs 
were found for the overall and minimum uniformities. 
The contrast was found to be negatively (but weakly) cor-
related with the MUs. On the other hand, for the 20 mA 
tube current, no correlation was observed for any image 
quality metrics.
The statistics (mean, standard deviation, minimum, 
and maximum) of the image quality metrics across the 16 
VMAT plans are summarized in Table 3. The number of 
kV projections acquired varied across the VMAT plans 
delivered with the CBCT acquisition: 617 ± 237 (346 
to 1194) for the 40 mA tube current. A statistically sig-
nificant correlation was observed between the MUs and 
number of projections acquired (r = 0.92, p = 0.00 for the 
20 mA tube current, r = 0.94, p = 0.00 for the 40 mA tube 
current). In other words, when more MUs were deliv-
ered, more kV projections were acquired. Therefore, the 
relationships found between the number of projections 
acquired and CBCT image quality metrics were similar 
to those between the MUs and CBCT image quality met-
rics as shown in Fig. 5.
Moreover, the impact of the tube current on the CBCT 
image quality can be observed from the image quality 
evaluation results presented in Table 3. The CNR, overall 
Table 2 Summary of four cone-beam CT imaging protocols with gantry speed adjusted for the pretreatment CBCT scans 
and corresponding image quality evaluation results
a The time for the in-treatment CBCT images was estimated for the case of delivering the VMAT plan for patient 1. In general, the time to acquire in-treatment CBCT 
images varies depending on the VMAT plan, which is concurrently delivered.
3D 4D
Pretreatment In-treatment Pretreatment In-treatment
Image acquisition parameters
 MV treatment beam No Yes No Yes
 Tube voltage (kV) 120 120 120 120
 Tube current (mA) 40 40 20 20
 Exposure time (ms) 40 40 16 16
 Collimator M20 M20 S20 S20
 Rotation angle (°) 360 360 200 200
 Gantry speed (°/min) 240 – 254 –
 Acquisition interval (°) – 0.1 – 0.1
 Estimated time (s)a 90 99 47 55
Analysis results
 #projections acquired 502 512 276 266
 Contrast (%) 9.5 10.1 7.9 5.5
 Contrast‑to‑noise ratio 14.9 9.5 6.3 2.6
 Overall uniformity (%) 98.7 98.0 96.4 89.1
 Minimum uniformity (%) 99.1 98.4 98.0 95.7
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uniformity, and minimum uniformity increased as the 
tube current increased from 20 to 40  mA. The mean 
and standard deviation of the CNR, overall uniform-
ity, and minimum uniformity values were 5.7% ± 1.2%, 
96.0% ± 2.5%, and 97.2% ± 0.7%, respectively, for the 
20  mA tube current vs. 8.5% ± 1.5%, 96.9% ± 1.9%, and 
98.2% ± 0.3%, respectively, for the 40 mA tube current.
Visibility and localization accuracy of lung target
It was not feasible to localize the lung target for sev-
eral of the intermediate phases, in which the target 
moved rapidly. Therefore, the localization accuracy 
of the lung target was analyzed and reported only for 
the 0- and 50-phases, which corresponded to the end-
of-exhalation and end-of-inhalation phases, respec-
tively. The resulting coordinates were compared to 
those obtained with the pretreatment 4D CBCT 
images. The localization results are summarized in 
Table 4. The absolute localization error for the 0-phase 
was 0.5 ± 0.4  mm for the 20  mA tube current and 
0.3 ± 0.2 mm for the 40 mA tube current. Sub-millim-
eter localization accuracy was also achieved for the 
50-phase: 0.3 ± 0.3 mm for the 20 mA tube current and 
0.1 ± 0.1  mm for the 40  mA tube current. Although a 
statistically significant correlation was found between 
the MU and 50-phase localization error for the CBCT 
images obtained with the 40 mA tube current, all of the 
values were quite small, ranging from − 0.3 to 0.1 mm. 
In general, the excursion estimated using in-treatment 
CBCT was smaller than the known motion magnitude 
(29.5  mm) for both tube currents; the excursion error 
was − 0.9 ± 0.5  mm for 20  mA and − 0.7 ± 0.2  mm for 
40 mA, indicating potential underestimation of the lung 
target excursion when using the in-treatment CBCT.
a b
c d
Fig. 4 Quantitative metrics to evaluate the 3D‑reconstructed in‑treatment Catphan CBCT image quality plotted vs. the tube current: a contrast, 
b contrast‑to‑noise ratio, c overall uniformity, and d minimum uniformity. The in‑treatment CBCT acquisition and image quality analysis were 
performed for different acquisition modes (partial‑arc vs. full‑arc) and different MV treatment beam energy values (6 vs. 10 MV FFF). The image 
quality metrics for the pretreatment CBCT acquired with the vendor‑recommended Symmetry protocol are represented as dashed lines in each 
graph
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In Fig.  6, the CNRs calculated for 10 respiratory 
phases are plotted against the MUs of the VMAT 
plans concurrently delivered: (a) mean across the res-
piratory phases, (b) 0-phase, and (c) 50-phase. Statisti-
cally significant correlations were found for the mean 
and 50-phase CNRs with the 40 mA tube current; the 
Pearson correlation coefficients were 0.62 and 0.56, and 
the corresponding p-values were 0.01 and 0.02, respec-
tively. On the other hand, weak correlations were found 
for the 0-phase CNR with the 40 mA tube current and 
all of the CNRs with the 20 mA tube current. As illus-
trated in Fig.  6, the p-values calculated by a paired 
t-test were 0.01 for the mean CNR, 0.00 for the 0-phase 
CNR, and 0.02 for the 50-phase CNR, indicating that 
the CNRs were significantly improved by increasing the 
tube current.
The CNRs calculated for the 16 VMAT plans for each 
of the 10 respiratory phases are presented as a box plot 
in Fig. 7. The CNR was higher for the extreme respiratory 
phases (exhalation and inhalation) than for the interme-
diate respiratory phases. An increase in the tube current 
resulted in an increase in the CNR for all respiratory 
phases.
Discussion
This study presents quantitative evaluation results of the 
image quality of in-treatment CBCTs obtained with the 
delivery of high dose rate VMAT plans using FFF X-ray 
Fig. 5 Scatter plots of the a contrast, b contrast‑to‑noise ratio, c overall uniformity, and d minimum uniformity calculated using the Catphan 
phantom against the monitor units. The CBCT image quality metrics were compared between the tube currents of 20 and 40 mA. The Pearson 
correlation coefficients r and corresponding p‑values p are presented
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beams, which has not been investigated in previous stud-
ies. The effect of the MV treatment beam scatter on the 
in-treatment CBCT image quality was quantitatively 
analyzed. Moreover, the effects of several important fac-
tors, such as the tube current, acquisition angle range, 
and MU of the VMAT plan, on the CBCT image quality 
were investigated. The visibility of the lung target in the 
XSight tracking phantom, which was evaluated in terms 
of CNR, provides useful information on how visible the 
lung target is on 4D in-treatment CBCTs acquired during 
VMAT-based lung SBRT.
The CBCT image quality was found to be degraded by 
the scattered MV FFF X-ray beams concurrently deliv-
ered with the CBCT acquisition. Image quality degrada-
tion due to the MV scatter was reported in the previous 
studies on in-treatment CBCT obtained with unflattened 
X-ray beams [13, 17, 18, 24]. Shimohigashi et al. demon-
strated that the in-treatment CBCT image quality was 
not significantly degraded when it was acquired with 
the delivery of VMAT plans using flattened X-ray beams 
[18]. However, in this previous study by Shimohigashi 
et al., the number of kV projections for the in-treatment 
CBCT was relatively large (979–1738) and the VMAT 
plans were delivered in a low dose rate using flattened 
X-ray beams. In contrast to the previous study, the in-
treatment CBCT images were acquired in a SBRT set-
ting, that is, with high dose rate VMAT delivery. For a 
fair comparison of the CBCT image quality between 
pretreatment and in-treatment CBCT images, the gantry 
speed for the pretreatment CBCT was adjusted, so that 
similar numbers of projections were obtained. All of the 
image quality metrics decreased due to the MV treat-
ment beam scatter as indicated in Table 2. For instance, 
the CNR decreased from 6.3 to 2.6 due to the MV beam 
scatter for the 4D CBCT.
It was demonstrated that the image quality of in-treat-
ment CBCT can be improved by increasing either the 
tube current or the angular range of the CBCT acquisi-
tion. The effect of the tube current on the CBCT image 
quality was evaluated using both the Catphan and XSight 
phantoms. As illustrated in Figs. 4 and 5, all of the image 
quality metrics calculated for the Catphan were improved 
Table 3 Statistics (mean, standard deviation, and range) of the number of projections, monitor units, and CBCT image 
quality metrics calculated across  16 VMAT plans compared between  the  CBCT images acquired with  the  tube currents 
of 20 and 40 mA
Furthermore, the Pearson correlation coefficients r and corresponding p-value p were calculated between the number of projections acquired and each of the other 
variables (the monitor units and CBCT image quality metrics)
Tube current: 20 mA Tube current: 40 mA






r p r p
Number of projections acquired 623 ± 225 (379–1170) 617 ± 237 (346–1194)
Monitor units 2063 ± 1221 (154–4525) 0.92 0.00 2063 ± 1221 (154–4525) 0.94 0.00
Contrast (%) 8.1 ± 0.5 (7.4–9.1) − 0.10 0.72 8.6 ± 0.5 (8.2–10.2) − 0.41 0.12
Contrast‑to‑noise ratio 5.7 ± 1.2 (3.1–8.1) − 0.04 0.89 8.5 ± 1.5 (5.4–10.8) 0.55 0.03
Overall uniformity (%) 96.0 ± 2.5 (87.1–98.0) 0.32 0.23 96.9 ± 1.9 (92.0–97.9) 0.48 0.06
Minimum uniformity (%) 97.2 ± 0.7 (95.6–98.0) 0.31 0.24 98.2 ± 0.3 (97.3–98.7) 0.59 0.02
Table 4 Statistics (absolute mean, standard deviation, and  range) of  the  localization errors of  the  lung target 
in the XSight tracking phantom (0-phase and 50-phase) and excursion errors were compared between the 20 and 40 mA 
tube currents
The Pearson correlation coefficients r with the MUs and corresponding p-value p are also provided.
a Mean values are provided for the excursion error.
Tube current: 20 mA Tube current: 40 mA
Absolute  meana, standard 
deviation (range)




r p r p
Localization error (mm): 0‑phase 0.5 ± 0.4 (− 0.6 to 1.0) 0.20 0.45 0.3 ± 0.2 (0.0 to 0.6) 0.36 0.16
Localization error (mm): 50‑phase 0.3 ± 0.4 (− 1.2 to 0.2) − 0.25 0.35 0.1 ± 0.1 (− 0.3 to 0.1) 0.62 0.01
Excursion error (mm) − 0.9 ± 0.5 (− 1.6 to 0.2) − 0.01 0.97 − 0.7 ± 0.2 (− 1.1 to 0.2) − 0.45 0.08
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by increasing the tube current. This positive effect of 
the tube current on the CBCT image equality was also 
demonstrated for the XSight lung tracking phantom. 
The CNR was improved by increasing the tube current 
from 20 to 40  mA, indicating an improvement in the 
lung target visibility. Furthermore, it was demonstrated 
that full-arc acquisition resulted in larger numbers of kV 
projections, thereby improving the quality of the recon-
structed image. Based on the results of this investigation, 
the use of a tube current of 32–50 mA is recommended 
to compensate for the negative effect of the MV scatter.
Although the CBCT imaging dose was not measured in 
this investigation, reasonable estimations of the resulting 
imaging dose can be made using the imaging dose val-
ues previously reported in the literature. Thengumpallil 
et al. measured the cone-beam dose index (CBDI) for the 
Elekta Symmetry protocol, with which 1320 projections 
were acquired with a 20  mA tube current during 200° 
gantry rotation; the measured CBDI was 17.6 mGy [25]. 
Supposing that the fractional dose for the lung SBRT is 
10 Gy (median across the 16 VMAT plans in this study), 
the 4D CBCT imaging dose is estimated to be 0.2% of the 
radiation dose for treatment. The mean number of kV 
projections acquired for the 4D in-treatment CBCT was 
617, which is approximately half of that for the 4D pre-
treatment CBCT in Thengumpallil et  al. Therefore, the 
imaging dose for 4D in-treatment CBCT with a 40  mA 
tube current is estimated to be, on average, similar to 
the imaging dose reported (17.6 mGy). For the patients, 
to whom high MUs are delivered, the imaging dose for 
4D in-treatment CBCT with a 40  mA tube current can 
be larger than the reported dose. For instance, in this 
study, the largest number of kV projections acquired was 
1194 in this investigation. The corresponding imaging 
dose can be estimated to be almost twice as high as the 
reported dose: 17.6 mGy × (1194/1320) × (40 mA/20 mA
) = 17.6 mGy × 1.8 = 31.7 mGy.
Furthermore, it was demonstrated how the MUs 




Fig. 6 Scatter plots of the a mean CNR across the phases, b 0‑phase 
CNR, and c 50‑phase CNR against the monitor units. The CBCT image 
quality metrics were compared between the tube currents of 20 
and 40 mA. The Pearson correlation coefficients and corresponding 
p‑values are also presented
Fig. 7 Box plots of the contrast‑to‑noise ratios calculated for the 
in‑treatment 4D CBCT images obtained with 16 VMAT plans for 
10 respiratory phases (0, 10, …, 90); 0 and 50 phases represent 
end‑of‑exhalation and end‑of‑inhalation phases, respectively, and the 
other phases represent intermediate phases
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image quality of in-treatment CBCT. For the in-treat-
ment CBCT, a large number of kV projections (or slow 
gantry rotation) was found to be highly correlated with 
large MUs. In other words, as the MUs increased (i.e. the 
gantry moved more slowly), a larger number of projec-
tions were obtained. While an improvement in the CBCT 
image quality is expected due to the increase in the num-
ber of projections acquired, image quality degradation 
could also be expected due to the increase in the MV 
scatter. The positive correlations found between the MUs 
and CNR demonstrated that the effect of the number of 
kV projections was dominant over that of the MV treat-
ment beam scatter. This finding suggests that in-treat-
ment CBCT should be acquired with an arc with higher 
MUs in the case of multiple-arc VMAT delivery.
The localization accuracy of a moving target was evalu-
ated using the XSight lung tracking phantom, in which a 
respiratory motion of a lung target was simulated with a 
specific breathing condition and target size. The motion 
range of approximately 3 cm, which was simulated in the 
XSight lung tracking phantom, was relatively large com-
pared to the lung motion ranges reported in the previ-
ous studies (see Table 1 in the report of the AAPM Task 
Group 76 [1]). Considering that the breathing cycle of 5 s 
is close to the average cycle, the evaluation of the target 
visibility and localization accuracy using the 4D in-treat-
ment CBCT was performed for a fast-moving lung target. 
Therefore, in this sense, a similar or superior localiza-
tion accuracy is expected for lung patients. However, this 
study is limited since the investigation was carried out for 
only one target size (2.5 cm). For smaller lung targets, the 
target localization may be more affected by the MV treat-
ment scatter artifacts. Although it was demonstrated that 
the lung target in the XSight tracking phantom was local-
ized with sub-millimeter accuracy, similar to the results 
in a recent study [20], target localization accuracy may be 
lower in patient cases.
Several studies have investigated the feasibility of 
reducing the MV treatment scatter effect on the in-
treatment CBCT image quality [13, 14, 24, 26]. The first 
work to acquire MV scatter-free CBCT images was per-
formed by Ling et al.; in this study, a control point was 
divided into two points, that is, a MV treatment con-
trol point and a kV imaging control point to minimize 
the interference between the MV and kV beams. One 
limitation of the proposed method is the increase in 
the radiation beam-on time. Another scatter correction 
method was suggested by van Herk et al. [24], in which 
kV imaging acquisition was alternated while MV treat-
ment beams were turned on throughout a gantry rota-
tion. In this previous work, MV scatter was estimated 
using kV-on and kV-off projections. However, a limi-
tation of the method proposed by van Herk et  al. was 
the decrease in the number of kV projections acquired, 
which had a negative effect on the CBCT image quality. 
Although a direct measurement method for MV scatter 
at the first treatment fraction was suggested by Boylan 
et al. [14], acquiring the in-treatment CBCT at the first 
fraction is inherently infeasible. Recently, a hardware-
based scatter correction approach [26] was suggested 
by Ouyang et al., but it has not been implemented for 
clinical use. Further investigations need to be per-
formed to establish a clinically feasible solution for MV 
scatter correction in in-treatment CBCT images.
Conclusion
The image quality of 4D in-treatment CBCT was 
degraded by the scatter of MV FFF treatment beams 
used for lung SBRT. In order to cope with the image 
quality degradation of 4D in-treatment CBCT, based 
on the evaluation results, full-arc acquisition with an 
increased tube current and the selection of a treatment 
beam with higher MUs is recommended. The respira-
tory motion range of a lung target can be accurately 
calculated using 4D in-treatment CBCT as shown 
by the localization accuracy of the lung target in the 
XSight tracking phantom. These results demonstrated 
that 4D in-treatment CBCT with the appropriate selec-
tion of acquisition parameters can be used to monitor 
intrafraction variation in the lung target position dur-
ing VMAT-based SBRT.
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